Sawai Group Holdings Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Sawai Group Holdings Co., Ltd.

Sawai Group Holdings Co., Ltd. (サワイグループホールディングス株式会社, 4887), Pharmaceutical. 11 cross-shareholdings, a board of 8 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YITS, filed 2026-06-24. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31193.8−28.3349.5−215.18130.002,968
2023-03-31163.712.7364.296.42130.003,393
2024-03-31176.913.7382.0104.22130.003,482
2025-03-31189.012.0354.696.54105.003,310
2026-03-31201.710.4359.990.3955.003,630

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
MEDIPAL HOLDINGS CORPORATION218,1000.60.1
Alfresa Holdings Corporation224,0000.60.1
Neurolief Ltd.595,7510.4—
Daito Pharmaceutical Co.,Ltd.193,6000.30.7
SUSMED,Inc.245,0000.21.5
TECHNO RYOWA LTD.31,4600.20.2
ASAHI PRINTING CO.,LTD.165,2000.10.8
Medical Ikkou Group Co.,Ltd.50,0000.11.3
Mitsubishi UFJ Financial Group, Inc.15,6000.00.0
Sumitomo Mitsui Financial Group, Inc.4,5000.00.0

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown